Trials / No Longer Available
No Longer AvailableNCT04321694
Expanded Access for KHK2455
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Kyowa Kirin, Inc. · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
This is an expanded access program for eligible participants. This program is designed to provide access to KHK2455 in combination with Mogamulizumab prior to the approval by the local regulatory agency. A medical doctor must decide whether the potential benefit outweighs the risk of receiving this investigational therapy based on the individual patients medical history and eligibility criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK2455 |
Timeline
- First posted
- 2020-03-25
- Last updated
- 2024-04-25
Source: ClinicalTrials.gov record NCT04321694. Inclusion in this directory is not an endorsement.